Crystal Tse

China’s top movie ticketing app Maoyan seeks up to $345m in Hong Kong IPO

Welight Capital and IMAX China unit will buy a combined $18 million of stock as cornerstone investors.

Anheuser-Busch InBev shares jump on report of Asian business IPO

The world’s largest brewer has been looking to reduce borrowings following its purchase of SABMiller Plc for more than $100 billion in 2016.

State Bank of India said to hire banks for $1.4b share sale

SBI’s sale will help bolster its capital buffers as it attempts to grow loans at a faster pace.

Chinese bitcoin mining chip-maker Canaan mulls US listing after shelving plans for HK IPO

The Chinese company, which was earlier targeting to raise about $1 billion, is discussing the possibility of selling shares in New York as soon as the first half.

Solar energy firm Xinyi said to postpone up to $582m Hong Kong IPO

Xinyi Energy is postponing the deal amid a broad equity selloff in Hong Kong, where the benchmark Hang Seng Index is down more than 20 percent since its January all-time high.

Chinese biotech firm WuXi AppTec said to raise $1b in HK share sale

WuXi AppTec is completing its offering after a slump in Chinese drug stocks amid concern the government is driving down generic drug prices.

Fosun may set Club Med’s Hong Kong IPO price at bottom range

Fosun Tourism Group is seeking to raise as much as $548 million in a Hong Kong IPO.

Tencent-backed Chinese startup Mogu said to raise $67m at bottom of IPO price

The price implies a market value of $1.3 billion, compared to the $4 billion the Chinese firm was targeting earlier this year.

Fosun Tourism Group seeks to raise $548m in Hong Kong IPO

The owner of luxury resort brand Club Med is offering 214.2 million shares at HK$15.60 to HK$20.00 apiece.

HNA unit Pactera secures funding lifeline from hedge funds

An $80 million loan secured by Pactera after more than a year of failed attempts to attract funding may just be another sign of the fragile financial state of the company and its debt-laden parent.